A Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam (0.25, 0.5 and 1.0 mg/kg/day) in Patients with Lennox-Gastaut Syndrome

Grants and Contracts Details

StatusFinished
Effective start/end date1/16/083/31/09

Funding

  • Inc Research Inc: $20,398.00